Goldman Sachs Initiates MAKO Surgical At Buy, $36 PT

May 17, 2011 6:43 AM | 7 seconds read |
Goldman Sachs has initiated coverage on MAKO Surgical MAKO with a Buy rating and $36 price target.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetInitiationAnalyst RatingsGoldman SachsHealth CareHealth Care Equipmentmako surgical
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!